Chronic oro-genital ulcerations as a presenting feature of chronic eosinophilic leukemia: A case report

Chronic oro-genital ulcerations as a presenting feature of chronic eosinophilic leukemia: A case report

Hypereosinophilia can be primary, including idiopathic hypereosinophilic syndrome (HES) and chronic eosinophilic leukemia, or secondary/reactive to various infective and non-infective stimuli. Chronic oro-genital ulcerations can occur due to various dermatological and non-dermatological disorders, a...

Full description

Bibliographic Details
Main Authors:	Jigna Padhiyar, Nayan Patel, Megha Lakum, Himal Shah
Format:	Article
Language:	English
Published:	Wolters Kluwer Medknow Publications 2023-01-01
Series:	Indian Dermatology Online Journal
Subjects:	chronic eosinophilic leukemia chronic oro-genital ulcerations hypereosinophilia imatinib mesylate pdgfra gene re-arrangement
Online Access:	http://www.idoj.in/article.asp?issn=2229-5178;year=2023;volume=14;issue=4;spage=524;epage=526;aulast=Padhiyar

Similar Items

Chronic eosinophilic leukemia with Fip 1-like 1-platelet-derived growth factor receptor alpha mutation: A rare case report
by: Khushboo Dewan, et al.
Published: (2015-01-01)

FIP1L1-PDGFRA-Positive Chronic Eosinophilic Leukemia: A Low-Burden Disease with Dramatic Response to Imatinib - A Report of 5 Cases from South India
by: Anıl Kumar N., et al.
Published: (2014-02-01)

Pruritus as a Presenting Symptom of FIP1L1-PDGFRA-Positive Chronic Eosinophilic Leukemia
by: Abu-Tineh M, et al.
Published: (2021-12-01)

Comorbidity of eosinophilic chronic rhinosinusitis in chronic eosinophilic pneumonia
by: Hiroatsu Hatsukawa, et al.
Published: (2023-11-01)

OUR EXPERIENCE WITH TREATMENT OF CHRONIC MYELOID LEUKEMIA WITH IMATINIB MESYLATE
by: Mojca Modic, et al.
Published: (2004-12-01)

Rapid Effect of Benralizumab for Hypereosinophilia in a Case of Severe Asthma with Eosinophilic Chronic Rhinosinusitis
by: Hiroaki Tsurumaki, et al.
Published: (2019-07-01)

Eosinophilic Colitis, an Uncommon Cause of Diarrhea: Case Report and Literature Review
by: Pedro Cardoso, et al.
Published: (2022-12-01)

Chronic subdural hematoma-unsual cause of headache in a patient with chronic myeloid leukemia treated with high-dose imatinib mesylate: A rare case report with review of literature
by: Sanjay M Khaladkar, et al.
Published: (2015-01-01)

Platelet Dysfunction in Patients with Chronic Myeloid Leukemia: Does Imatinib Mesylate Improve It?
by: Olga Meltem Akay, et al.
Published: (2016-05-01)

Imatinib Therapy in Chronic Myelogenous Leukemia and Thyroid Function Tests
by: Mohammad Ali Mashhadi, et al.
Published: (2014-09-01)

OUR EXPERIENCE IN TREATMENT OF CHRONIC MYELOID LEUKEMIA WITH IMATINIB MESYLATE
by: Marjana Glaser, et al.
Published: (2004-04-01)

Molecular Monitoring of Chronic Myeloid Leukemia in Chronic Phase (CML-CP)
by: Mehrdad Payandeh, et al.
Published: (2018-12-01)

Outcome of imatinib mesylate in women with child-bearing age diagnosed with chronic myeloid leukemia
by: Alaa Fadhil Alwan, et al.
Published: (2021-01-01)

Efficacy of imatinib mesylate-based front-line therapy in pediatric chronic myelogenous leukemia
by: Hyun Jin Oh, et al.
Published: (2013-08-01)

Imatinib Mesylate (STI 571) – A New Oral Target Therapy For Chronic Myelogenous Leukemia (CML)
by: Ladislav Chrobák, et al.
Published: (2003-01-01)

O tratamento da Leucemia Mielóide Crônica com mesilato de imatinibe Therapy of Chronic Myeloid Leukemia with imatinib mesylate
by: Vaneuza M. Funke, et al.
Published: (2008-04-01)

Renal tuberculosis in an imatinib-treated chronic myeloid leukemia
by: Abhilash Chandra, et al.
Published: (2020-04-01)

Severe Dizziness and Hypereosinophilia: Coincidence or Complication? A Case Report
by: Giorgia Lo Presti, et al.
Published: (2020-09-01)

Positive response to imatinib mesylate therapy for childhood chronic myeloid leukemia
by: G.A.P. Oliveira, et al.
Published: (2010-06-01)

The efficacy of generic imatinib in patients with chronic myeloid leukemia: A single centre experience
by: Urošević Ivana, et al.
Published: (2021-01-01)

Imatinib Mesylate (Glivec) in Pediatric Chronic Myelogenous Leukemia
by: Gholamreza Bahoush, et al.
Published: (2009-07-01)

Imatinib Mesylate (Glivec) in Pediatric Chronic Myelogenous Leukemia
by: Gholamreza Bahoush, et al.
Published: (2009-09-01)

Assessment of fibrosis and vascularization of bone marrow stroma of chronic myeloid Leukemia patients treated with imatinib mesylate and their relationship with the cytogenetic response
by: Caroline Regina de Jesus, et al.
Published: (2011-06-01)

Leucemia Mielóide Crônica em pediatria: perspectivas atuais Chronic Myeloid Leukemia in pediatrics patients: current approach
by: Maria Lucia M. Lee
Published: (2008-04-01)

OCCURRENCE OF SECONDARY MALIGNANCIES IN CHRONIC MYELOID LEUKEMIA DURING THERAPY WITH IMATINIB MESYLATE-SINGLE INSTITUTION EXPERIENCE
by: Grzegorz Helbig, et al.
Published: (2015-01-01)

Chronic-phase chronic myeloid leukemia: Incidence of BCR/ABL transcript and its correlation with presenting features, response to treatment, and survival
by: Baraa Laabidi, et al.
Published: (2023-01-01)

Study of correlation between imatinib mesylate plasma levels and hematological profile of patients undergoing treatment for chronic myeloid leukemia
by: Emanuelle S. Dal Ponte, et al.
Published: (2017-06-01)

Chronic eosinophilic leukemia with FIP1L1-PDGFRA transcripts after occupational and therapeutic exposure to radiation
by: Gueorgui Balatzenko, et al.
Published: (2011-10-01)

A lepidic adenocarcinoma mimicking an eosinophilic lung
by: L. Senhaji, et al.
Published: (2022-01-01)

A case of juvenile eosinophilic cholangitis: Rapid peripheral blood hypereosinophilia after admission leading to diagnosis
by: Shusaku Fukatsu, et al.
Published: (2021-02-01)

Cough in hypereosinophilic syndrome: case report and literature review
by: Jiaxing Xie, et al.
Published: (2020-04-01)

Invasive Pulmonary Aspergillosis with Marked Eosinophilia as a Unique Presentation of Chronic Granulomatous Disease
by: Julie Van Woensel, et al.
Published: (2022-07-01)

Editorial: Severe Eosinophilic Disorders: Mechanisms and Clinical Management
by: Praveen Akuthota, et al.
Published: (2019-09-01)

Usefulness of eosinophilic cationic protein as a marker of eosinophilic myocarditis in a child
by: Reiko Ito, et al.
Published: (2003-01-01)

A conserved ZFX/WNT3 axis modulates the growth and imatinib response of chronic myeloid leukemia stem/progenitor cells
by: Xiuyan Zhang, et al.
Published: (2023-10-01)

Adherence and/or discontinuation of imatinib mesylate in patients with chronic myeloid leukemia
by: Alexandra Rodrigues Alves, et al.

Could the Epigenetics of Eosinophils in Asthma and Allergy Solve Parts of the Puzzle?
by: Émile Bélanger, et al.
Published: (2021-08-01)

Sphingomyelin synthase 1 activity is regulated by the BCR-ABL oncogene[S]
by: Tara Ann Burns, et al.
Published: (2013-03-01)

Imatinib-Induced Interstitial Pneumonitis Successfully Switched to Nilotinib in a Patient with Prior History of Mycobacterium tuberculosis Infection
by: Zhuan - Bo Luo, et al.
Published: (2017-11-01)

Analysis of clinical characteristics of 25 patients with hypereosinophilia complicated with peripheral arterial occlusion
by: HAN Yingdong, WANG Song, HAN Xinxin, YIN Yue, WANG Yu, ZHANG Yun, ZENG Xuejun
Published: (2023-05-01)